Eur Rev Med Pharmacol Sci 2024; 28 (12): 3806-3806
DOI: 10.26355/eurrev_202406_36449

J. Sun, X. Zhang, L. Wang, A.F.D. Di Stefano, V. Zanin, P. Magrone, Y. Yuan

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Eur Rev Med Pharmacol Sci 2023; 27 (24): 12103-12111–DOI: 10.26355/eurrev_202312_34808–PMID: 38164872, published online on December 22, 2023.

After publication, the authors found that Table III’s legend was the same as that of Table II.

Therefore, Table III’s legend has been corrected as follows: Table III. Plasma PK parameters following repeat doses of IV NAC 600 mg (n = 24).

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

J. Sun, X. Zhang, L. Wang, A.F.D. Di Stefano, V. Zanin, P. Magrone, Y. Yuan
Author Correction: Phase I study of the pharmacokinetics and safety of single and multiple doses of intravenous N-acetylcysteine in healthy Chinese subjects

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 12
Pages: 3806-3806
DOI: 10.26355/eurrev_202406_36449

Tag: Erratum